MRI-guided Ultrahypofractionated SBRT Prostate Program

Inclusion Criteria

• •Patients with low to favorable intermediate-risk prostate cancer as per the NCCN stratification criteria .
• •No prior radiation therapy to the target areas
• •Expected patient survival \>5 years
• •Patient able to undergo a MRI exam
• •Suboptimal candidates for high-dose therapy such as elderly, frail patients or patients with large volume glands (i.e, \>60cm3) or extensive TURP in the prior 6-12 months should be considered cautionary indications.
• •Patients with higher risk but low volume disease not candidates for ENI may be treated on an individual basis